Development will boost life sciences sector by delivering significant lab space in Cambridge
News
Positive results from trial of Arecor’s insulin candidate AT247
Therapy demonstrates significantly accelerated insulin absorption and early exposure
AlzeCure demonstrates disease-modifying effects of NeuroRestore ACD856
Data from the study shows that ACD856 has a potential neuroprotective effect in a cellular mode
Brainomix in collaboration with UK Government-funded NCIMI
Partnership will evaluate AI-powered technology in lung cancer care
LifeArc and MRC launch toolkit to navigate medicines repurposing
Medicines repurposing offers new avenues for treating a range of common and rare diseases
Ziphius vaccines and UZ Ghent establish vaccine collaboration
First EU public-private collaboration for production of saRNA-based vaccines
OPTIMA announce AstraZeneca and Mutabor as official partners
The companies will aim to improve treatment for patients with prostate, breast and lung cancer
FlyPharma: airea
The Airport Region in Central Germany’ presents itself as an attractive location for the international pharmaceutical industry
Amphista partners with Domainex to advance drug portfolio
Partnership will maximise the chance of successfully progressing its research projects
NPA in partnership with Charac to accelerate the digital transformation
Link up will boost independent community pharmacies’ online presence to broaden services
Scientists awarded £1m to help women make childbirth choices
Group will develop an aid that can be used to guide discussion between pregnant women
ALTURiX Acquires UK rights to desmopressin oral solution
Deal is part of mission to increase options available prescribers, patients and the NHS
FlyPharma Conference Europe 2022 shares the latest supply chain challenges and advice for better industry collaboration
On 20-21 September 2022, the FlyPharma Conference Europe made a welcome return as a live, in-person event
Eli Lilly receives marketing authorisation for baricitinib
Treatment involves adult patients with severe alopecia areata
‘Junk’ DNA may hold the key to neurological disorders
University of Lincoln and the University of Sheffield are researching how DNA could be repaired
